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The first isolation in the UK of Balamuthia mandrillaris amoebae from a fatal case of granulomatous
amoebic meningoencephalitis is reported. Using primary cultures of human brain microvascular
endothelial cells (HBMECs), amoebae were isolated from the brain and cerebrospinal fluid (CSF).
The cultures showed a cytopathic effect at 20–28 days, but morphologically identifiable B.
mandrillaris amoebae were seen in cleared plaques in subcultures at 45 days. The identification of
the organism was later confirmed using PCR on Chelex-treated extracts. Serum taken while the
patient was still alive reacted strongly with slide antigen prepared from cultures of the post-mortem
isolate, and also with those from a baboon B. mandrillaris strain at 1 : 10 000 in indirect
immunofluorescence, but with Acanthamoeba castellanii (Neff) at 1 : 160, supporting B.
mandrillaris to be the causative agent. If the presence of amoebae in the post-mortem CSF reflects
the condition in life, PCR studies on CSF and on biopsies of cutaneous lesions may also be a
valuable tool. The role of HBMECs in understanding the interactions of B. mandrillaris with the
blood–brain barrier is discussed.
INTRODUCTION
Free-living amoebae such as Naegleria, Acanthamoeba and
Balamuthia are potential pathogens with increasing impor-
tance in human health, and are known to produce two fatal
diseases, primary amoebic meningoencephalitis (PAM) and
granulomatous amoebic encephalitis (GAE). PAM, caused
byNaegleria fowleri, is a fast progressing disease (lasting 7–14
days), affecting both immunocompromised and immuno-
competent hosts. N. fowleri gains entry into the central
nervous system (CNS) through the olfactory neuroepithe-
lium, producing necrotizing and haemorrhagic meningoen-
cephalitis, and is associated with stiff neck, headache,
vomiting, fever and nausea (Barnett et al., 1996; Ferrante,
1991; Ma et al., 1990; Martinez & Visvesvara, 1997, 2001). In
contrast, GAE can be caused by bothBalamuthiamandrillaris
and Acanthamoeba species and is thought to be initiated by
the entry of amoebae through the lower respiratory tract or
skin lesions, followed by haematogenous spread (reviewed by
Khan, 2003; Marciano-Cabral & Cabral, 2003). Circulating
amoebae most likely gain access through the blood–brain
barrier to enter the CNS (Khan, 2003). GAE is characterized
by subacute or chronic granulomatous encephalitis with
clinical features such as stiff neck, headache, fever, confusion,
nausea and seizures (Marciano-Cabral & Cabral, 2003).
These conditions can persist from several weeks to months
with fatal consequences. The predisposing factors for GAE
due to Acanthamoeba include alcoholism, drug abuse,
steroid treatment, cancer chemotherapy, radiotherapy and
organ transplantation (Anderlini et al., 1994; Martinez &
Janitschke, 1985; Sell et al., 1997). In general, conditions that
lead to immune suppression contribute to enhanced suscept-
ibility to GAE due to Acanthamoeba. However, more worry-
ingly, B. mandrillaris apparently produces GAE irrespective
of the status of the host immune system. This is of particular
concern as there are no definitive treatments available for
Abbreviations: CSF, cerebrospinal fluid; GAE, granulomatous amoebic
meningoencephalitis; HBMECs, human brain microvascular endothelial
cells; LDH, lactate dehydrogenase.
these fatal diseases. Recently, we have developed an in vitro
model of the blood–brain barrier by isolating human brain
microvascular endothelial cells (HBMECs) (Alsam et al.,
2003). Using this model, we have isolated B. mandrillaris
from the brain necropsy as well as the post-mortem
cerebrospinal fluid (CSF) of an immunocompetent GAE
patient. These results were further confirmed using PCR and
indirect immunofluorescence assays.
METHODS
Chemicals.All chemicals were purchased from Sigma, unless otherwise
stated.
HBMECs. Primary BMECs of human origin were isolated and cultured
as previously described (Alsam et al., 2003). Briefly, HBMECs were
purified by fluorescence-activated cell sorting, and their purity was
tested using endothelial markers such as expression of F-VIII and
carbonic anhydrase IV and uptake of acetylated low-density lipoprotein
(AcLDL). The resulting cultures were more than 99 % pure. HBMECs
were routinely grown on rat tail collagen coated dishes in RPMI
(Invitrogen) containing 10 % heat-inactivated fetal bovine serum,
10 % Nu-Serum, 2 mM glutamine, 1 mM pyruvate, penicillin (100 U
ml1), streptomycin (100 g ml1), non-essential amino acids and
vitamins.
B. mandrillaris cultures. A standard isolate (ATCC 50209) of B.
mandrillaris, isolated from the brain of a mandrill baboon, was routinely
cultured on HBMEC monolayers. Briefly, 106 amoebic trophozoites
were inoculated on HBMEC monolayers in RPMI containing 2 mM
glutamine, 1 mM pyruvate and non-essential amino acids. Flasks were
incubated at 37 8C in a 5 % CO2 incubator and observed daily. A
complete HBMEC monolayer degradation was observed within 3–4
days when the amoebic numbers had reached approximately 5 3 106,
more than 99 % of which were trophozoites. These were subsequently
used in PCR, immunofluorescence and cytotoxicity assays.
Isolation of B. mandrillaris from the post-mortem sample of the
infected patient. The post-mortem samples, i.e. the brain necropsy
and the CSF, were derived from a 33-year-old immunocompetent male
who died of GAE subsequent to suffering from skin lesions which
developed following a traffic accident in Bolivia. The patient had no
history of HIV infection or of being immunocompromised and his CD4
count was only slightly depressed (621 cells l1; normal range 775–
1385 cells l1). Both the brain necropsy and the CSF specimens were
inoculated on HBMEC monolayers in tissue culture flasks. Flasks were
incubated at 37 8C in a 5 % CO2 incubator and observed daily for the
presence of B. mandrillaris as previously described (Schuster, 2002).
DNA extraction. For PCR reactions, DNA extractions were performed
as previously described (Khan et al., 2001). Briefly, 3 3 106 amoebae
were harvested by centrifugation at 700 g for 10 min. The cell pellet was
washed three times with PBS and finally resuspended in 0.5 ml PBS in
microcentrifuge tubes. To this, 0.5 ml lysis buffer (100 mM KCl, 40 mM
Tris, 5 mM MgCl2, 1 % Tween and 200 g proteinase K ml1) was
added and tubes were incubated at 56 8C for 60 min followed by 10 min
incubation at 100 8C. Finally the reaction mixtures were centrifuged at
2000 g for 5 min, and supernatant DNA was quantified and used as the
PCR template.
For clinical purposes it will be important to have a sensitive assay which
can identify B. mandrillaris at low cell numbers. Previously, we have
shown that Chelex can be potentially used to isolate DNA from fewer
cells as it does not involve washing steps or DNA precipitation which
could result in the loss of the DNA (Khan et al., 2001). Briefly, cell counts
were performed on the washed pellet (counted using a haemocyt-
ometer), volumes containing approximately 50, 100 and 1000 cells were
placed in 0.5 ml microcentrifuge tubes and 30 l Chelex (insta-gene
matrix; Bio-Rad) was added to each tube. Tubes were incubated at 56 8C
for 20 min and at 100 8C for 10 min and finally centrifuged at 2000 g for
5 min. The supernatant was used as the DNA template.
PCR analysis. B. mandrillaris genus-specific primers were used for the
PCR amplification of the mitochondrial 16S rRNA gene as previously
described (Booton et al., 2003). Primer sequences were: 59Balspec 16S,
59-CGCATGTATGAAGAAGACCA-39; and 39Balspec 16S, 59-TTACC-
TATATAATTGTCGATACCA-39. Briefly, PCR was performed in a
volume of 50 l containing 1.25 U Taq polymerase (Qiagen), 0.2–
0.4 g DNA, 200 M dNTPs, 2 mM MgCl2 and 2 M primer. The PCR
reactions were performed at 94 8C for 1 min, 48 8C for 2 min and 72 8C
for 3 min for 40 cycles with a final elongation step of 15 min at 72 8C.
Amplified DNA was electrophoresed on a 1 % agarose gel, stained and
visualized under UV illumination.
Indirect immunofluorescence assays for anti-amoebic antibody.
To detect anti-B. mandrillaris antibodies in the sera of the infected
patient, indirect immunofluorescence assays were performed. Briefly,B.
mandrillaris (baboon isolate) was collected by centrifugation at 2000 g
for 5 min and resuspended in 10 ml PBS. This process was repeated
three times. Finally, 100–500 B. mandrillaris trophozoites were dis-
pensed in 5 l PBS on Hendley Essex Multispot microscope slides (24
wells), allowed to dry, fixed with ice-cold 100 % acetone for 1 h, dried,
and stored wrapped in tissue paper in a sealed box with silica gel at
20 8C until needed. On recovery from the freezer the wrapped slides
were allowed to warm to room temperature in a desiccator. Wells were
incubated in a moist box with dilutions of the patient’s serum in PBS
containing 2 % dried milk (‘Marvel’) for 30 min at room temperature,
washed in PBS, incubated with 1/120 FITC-labelled goat anti-human
polyclonal antibody (30 min, room temperature), and visualized under
blue-light epifluorescence (Schuster et al., 2003).
Cytotoxicity assay. To further determine the pathogenic potential of
B. mandrillaris isolates used in this study as well as to develop an in vitro
model to study Balamuthia pathogenesis, cytotoxicity assays were
performed (Alsam et al., 2003). Briefly, HBMECs were grown to
confluency in 24-well plates. B. mandrillaris isolates (53105 amoebae
per well) were incubated with cell monolayers in serum-free medium
(RPMI 1640 containing 2 mM glutamine, 1 mM pyruvate and non-
essential amino acids) at 37 8C in a 5 % CO2 incubator for up to 48 h. At
the end of this incubation period, supernatants were collected and
cytotoxicity was determined by measuring lactate dehydrogenase
(LDH) release (cytotoxicity detection kit; Roche Applied Science).
Briefly, conditioned media of co-cultures of B. mandrillaris and
HBMECs were collected and the percentage LDH was detected as
follows: (sample valuecontrol value/total LDH releasecontrol
value3100 ¼ % cytotoxicity). Control values were obtained from
HBMECs incubated in RPMI alone. Total LDH release was determined
from HBMECs treated with 1 % Triton X-100 for 30 min at 37 8C.
RESULTS
Amoebae isolated from the GAE patient were
identified as B. mandrillaris based on morphology
The post-mortem brain and CSF specimens from the GAE
patient were inoculated on HBMEC monolayers and ob-
served daily for the presence ofB.mandrillaris. Within 20–28
days of incubation, HBMEC monolayers were disrupted;
however, no amoebae were observed. Supernatants were
collected and inoculated on fresh HBMEC monolayers. On
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day 40–45, the presence of a large number of B. mandrillaris
trophozoites (based on morphological characteristics, in
particular movement by characteristic pseudopods) was
observed (Fig. 1). Upon further incubation, we observed
transformations of the trophozoites into cysts (Fig. 1). Cysts
were further inoculated on HBMEC monolayers to obtain
large numbers of B. mandrillaris to use in all subsequent
assays.
PCR confirms clinical isolate as B. mandrillaris
To confirm the identification of amoebae isolated from the
post-mortem specimens as B. mandrillaris, PCR methods
were employed using Balamuthia-specific primers (Booton
et al., 2003). These primers are derived from the mitochon-
drial 16S rRNA gene (rns) and specifically amplify a product
from the whole-cell DNA of B. mandrillaris but not from
other amoebae such as Acanthamoeba, indicating their
potential value as a diagnostic tool (Booton et al., 2003).
Using this primer pair, we yielded a single expected PCR
product of 1075 bp, further confirming the clinical isolate as
B. mandrillaris (Fig. 2a, lanes 3 and 4). The DNA isolated
from B. mandrillaris (baboon) was used as a positive control
and gave a similar PCR product (Fig. 2, lane 2). Moreover,
the primers were specific for B. mandrillaris and did not give
any PCR product with HBMEC DNA (Fig. 2a, lane 5).
Next we determined the potential of this assay in the sensitive
detection of B. mandrillaris. To achieve this, we used Chelex
to extract DNA from B. mandrillaris and PCR amplifications
were performed as described above. The DNA from as few as
100 cells could be detected with the Balamuthia-specific
primers using the Chelex method (Fig. 2b). Overall, these
assays confirmed the identity of amoebae isolated from the
post-mortem specimen of the GAE patient asB. mandrillaris.
The use of Chelex resulted in a satisfactory sensitivity for
detecting the presence of B.mandrillaris in early cultures. For
sensitive detection on clinical samples the development of a
nested protocol based on the same multiple target may be
necessary.
Serum from the GAE patient reacts strongly with B.
mandrillaris (baboon isolate)
To determine the presence of Balamuthia antibodies in the
GAE patient, antigens from B. mandrillaris (baboon isolate)
were reacted with the patient’s serum using indirect im-
munofluorescence assays. We demonstrated that antiserum
Fig. 1. Amoebae isolated using HBMECs from a granulomatous meningoencephalitis patient are B. mandrillaris based on
morphology. Both the brain and the CSF specimens were incubated with HBMEC monolayers for several weeks as described in
Methods. B. mandrillaris was observed by phase-contrast microscopy. (a) Trophozoite; (b) immature cyst; and (c) both. Note the large
slender pseudopods (characteristic of B. mandrillaris, and showed visible motion). Magnification: 3200 (a, c); 3400 (b).
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reacted strongly against B. mandrillaris with a titre of
1 : 10 000, further supporting the infecting organism to be
B. mandrillaris (Fig. 3).
B. mandrillaris isolate from the GAE patient
exhibited severe HBMEC cytotoxicity
To determine the effects of the human isolate of B.
mandrillaris on HBMECs and to develop an in vitro model
for the study of Balamuthia pathogenesis, cytotoxicity assays
were performed. Briefly, B. mandrillaris was incubated with
HBMEC monolayers grown in 24-well plates. We demon-
strated that co-incubations of B. mandrillaris with the host
cells resulted in severe HBMEC monolayer disruptions
within 24 h (75.7  6 %; Fig. 4). In addition, LDH assays
revealed that the human isolate of B. mandrillaris produced
82.5  3.2 % HBMEC cytotoxicity within 24 h, further
confirming its pathogenic potential. This assay will be of
potential value in understanding the precise mechanisms
associated with B. mandrillaris-mediated host cell cytotoxi-
city.
DISCUSSION
This is the first report demonstrating the isolation of B.
mandrillaris from a case of GAE in the UK. The patient was a
young South American male, aged 33, who presented with
characteristic skin lesions, acute confused state and multiple
cerebral lesions involving extensive right hemispheric oede-
ma and hydrocephalus under CT scan, which proved fatal
within a few months of the onset of the disease. Previous
reports have suggested that free-living amoebae which cause
fatal GAE are opportunistic protozoan parasites causing
infections in immunocompromised hosts. In support, al-
most all reported GAE infections due to Acanthamoeba have
been reported in immunocompromised patients. The patient
had no history of HIV infection or of being immunocom-
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Fig. 2. (a) Identity of B. mandrillaris from the brain tissue and the CSF
specimen of the infected patient were confirmed using PCR. Agarose
gel showing amplification of mitochondrial 16S rRNA of B. mandrillaris
as described in Methods. Lanes: 1, 100 bp DNA ladder; 2, baboon
isolate of B. mandrillaris; 3, B. mandrillaris from brain tissue of the GAE
patient; 4, B. mandrillaris from the CSF specimen of the GAE patient;
5, DNA from HBMECs; 6, negative control. Note that both the brain
and the CSF amoebae gave a PCR product confirming their identity as
B. mandrillaris. The DNA from HBMECs did not give any product,
indicating the specificity of the primers. (b) Use of Chelex to extract
DNA for the sensitive detection of B. mandrillaris. DNA was extracted
from 50, 100 and 1000 cells using Chelex and used for PCR reactions
as described in Methods. Note that the PCR product was observed
with as few as 100 cells. B. mandrillaris (baboon isolate) was used as a
positive control.
Fig. 3. Serum from the GAE patient strongly reacted with B. man-
drillaris (baboon isolate). To determine the presence of Balamuthia
antibodies in the GAE patient, antigens from B. mandrillaris (baboon
isolate) were reacted with the patient’s serum using indirect immuno-
fluorescence assays as described in Methods. Note that the antiserum
reacted strongly against B. mandrillaris from the patient with a titre of
1 : 10 000, further confirming the amoebae to be B. mandrillaris.
Magnification: 333 (a) and 3133 (b).
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promised and his CD4 count was only slightly depressed
(621 cells l1; normal range 775–1385 cells l1). This
finding suggests that B.mandrillaris can cause fatal infections
in relatively immunocompetent adults and this is supported
by the finding of this organism in immunologically normal
children (Hansman et al., 1996; Healy, 2002; Katz et al., 2000;
Reed et al., 1997; Rowen et al., 1995; Yang et al., 2001),
confirming the previous notion that B. mandrillaris is more
virulent than Acanthamoeba (Huang et al., 1999).
One of the novel findings in our study is the isolation of B.
mandrillaris from the post-mortem CSF sample of the
infected patient. To our knowledge, this is the first report
describing the CSF isolation of B. mandrillaris. If this reflects
the condition in life, it is possible that B. mandrillaris entry
into the CNS may occur at the choroid plexus, the CSF
formation site. Haematogenous spread is thought to be the
route of entry, and this might take place through the highly
vascular choroid plexus. The presence of multiple skin
lesions on the infected patient would provide direct access
to the circulation for the parasites. However, once in the
circulation, parasites must interact with and penetrate the
blood–brain barrier. The blood–brain barrier is highly
selective, restricting the entry of pathogens, toxins, drugs as
well as large molecules, and the precise mechanisms used by
B. mandrillaris to cross the blood–brain barrier remain
unclear. Further studies to understand B. mandrillaris
penetration of the blood–brain barrier will undoubtedly
help develop novel strategies to prevent and treat these
serious infections.
Another interesting finding was the observation of a high B.
mandrillaris serological titre of 1 : 10 000 in the infected
patient. This titre is well above the range in non-infected
hosts with B. mandrillaris titre at 1 : 64–1 : 256 (Huang et al.,
1999) and suggests that the patient’s immune system
responded strongly to the parasite’s antigen(s); however,
the absence of a protective response remains unexplained.
This may well be due to the overwhelming infection or to the
ability of B. mandrillaris to employ strategies to evade host
immune systems. Further studies are in progress to address
these issues.
Several lines of evidence suggest that early diagnosis of GAE
due to B. mandrillaris may help successful therapy. This is
supported by recent studies of Deetz et al. (2003), who have
shown that early initiation of antimicrobial therapy resulted
in successful treatment of Balamuthia encephalitis in two
cases (a 5-year-old girl and 64-year-old man). To this end,
indirect immunofluorescence has been successfully used
(Huang et al., 1999) and may provide a useful diagnostic
tool. Similar findings were observed in this study, further
supporting the use of indirect immunofluorescence as an
early marker for GAE due to B. mandrillaris. In addition, we
employed PCR using Balamuthia-specific primers as pre-
viously described (Booton et al., 2003). A PCR product of
1075 bp was observed, further confirming the identity of the
isolated amoebae as B. mandrillaris. However, the clinical
diagnosis requires the identification of the parasites at low
cell numbers. To achieve this, we made use of Chelex to
isolate DNA from B. mandrillaris. This method does not
involve washing or precipitation steps, thus eliminating loss
of the DNA. Using this method, we were able to identify B.
mandrillaris with as few as 100 cells using Balamuthia-
specific primers. This method provides further tools for the
diagnosis of B. mandrillaris in clinical applications.
In this study, we were able to isolateB.mandrillaris from both
post-mortem samples including the brain necropsy and the
CSF using primary HBMECs as feeder layers. Previous
studies have successfully made use of African green monkey
kidney cells to isolate B. mandrillaris from brain tissues
(Schuster, 2002). However, primary HBMECs are physiolo-
gically most relevant in the actual infection as these cells
constitute the blood–brain barrier. They may thus provide a
useful tool for B. mandrillaris isolation from the CSF as well
as to understand the precise mechanisms of B. mandrillaris
passage across the blood–brain barrier, which may help
develop novel strategies for therapeutic interventions.
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Fig. 4. Baboon and GAE isolates of B. mandrillaris produced severe
HBMEC cytotoxicity. Both isolates (53105 per well) were added to
HBMEC monolayers in 24-well plates and cultures were incubated in
a 5 % CO2 incubator at 37 8C for 24 h. HBMECs without parasites
were used as controls. After this incubation, cytotoxicity was deter-
mined visually by haematoxylin staining. Results are representative of
three independent experiments performed in duplicate. Note that both
isolates produced HBMEC monolayer disruptions.
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